Lipid mediators in the nucleus: Their potential contribution to Alzheimer's disease.

Degradation of glycerophospholipids, sphingolipids and cholesterol in the nucleus modulates neural cell proliferation and differentiation, inflammation, apoptosis, migration, cell adhesion, and intracellular trafficking. Extracellular signals from agonists (neurotransmitters, cytokines, and growth factors) regulate the activity of a key set of lipid-metabolizing enzymes, such as phospholipases, sphingomyelinases, and cholesterol hydroxylases. These enzymes and their downstream targets constitute a complex lipid signaling network with multiple nodes of interaction and cross-regulation through their lipid mediators, which include eicosanoids, docosanoids, diacylglycerols, platelet activating factor, lysophosphatidic acid, ceramide and ceramide 1-phosphate, sphingosine and sphingosine 1-phosphate, and hydroxycholesterols. Receptors for above lipid mediators are localized at the neural cell nucleus. Stimulation of isolated nuclei with these lipids and agonists results in changes in transcriptional regulation of major genes, including c-fos, cylooxygenase-2, secretory phospholipase A(2) and endothelial as well as inducible nitric oxide synthases. Imbalances in signaling network involving above genes may contribute to the pathogenesis of human neurological disorders. In this review, we have attempted to integrate available information on above lipid mediators in the nucleus. In addition, attempts have been made to explain cross-talk among glycerophospholipid-, sphingolipid-, and cholesterol-derived lipid mediators in neural cell death in Alzheimer's disease.

[1]  N. Zini,et al.  Topology of inositol lipid signal transduction in the nucleus , 1999, Journal of cellular physiology.

[2]  T. Perlmann,et al.  Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. , 2000, Science.

[3]  Y. Awasthi,et al.  4-Hydroxynonenal self-limits fas-mediated DISC-independent apoptosis by promoting export of Daxx from the nucleus to the cytosol and its binding to Fas. , 2008, Biochemistry.

[4]  S. Monier,et al.  Impairment with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occuring during 7-ketocholesterol-induced apoptosis. , 2000, Free radical biology & medicine.

[5]  S. Serini,et al.  n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. , 2007, Current medicinal chemistry.

[6]  D. Adam,et al.  Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor , 1998, Journal of leukocyte biology.

[7]  A. Howlett,et al.  CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells. , 1998, Brain research. Molecular brain research.

[8]  A. Martelli,et al.  Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? , 2006, Cellular signalling.

[9]  G. Barrett.  The p75 neurotrophin receptor and neuronal apoptosis , 2000, Progress in Neurobiology.

[10]  A. Martelli,et al.  Nuclear inositol lipid metabolism: More than just second messenger generation? , 2005, Journal of cellular biochemistry.

[11]  D. Russell,et al.  Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. , 2009, Annual review of biochemistry.

[12]  T. Montine,et al.  4‐Hydroxy‐2(E)‐Nonenal Inhibits CNS Mitochondrial Respiration at Multiple Sites , 1999, Journal of neurochemistry.

[13]  E. Berdyshev,et al.  Cannabinoid receptors and the regulation of immune response. , 2000, Chemistry and physics of lipids.

[14]  M. Czubryt,et al.  RanGAP-Mediated Nuclear Protein Import in Vascular Smooth Muscle Cells Is Augmented by Lysophosphatidylcholine , 2007, Molecular Pharmacology.

[15]  B. Halliwell,et al.  Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A2 inhibitors , 2001, Brain Research Reviews.

[16]  E. Albi,et al.  Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus. , 2008, The Biochemical journal.

[17]  L. Horrocks,et al.  Phospholipids in the nervous system , 1982 .

[18]  M. Schumacher,et al.  25‐hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR , 2009, Journal of neurochemistry.

[19]  L. Horrocks,et al.  Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide , 2007, Journal of neuroscience research.

[20]  A. A. Farooqui.  Excitotoxicity-Mediated Neurochemical Changes in Neurological Disorders , 2009 .

[21]  H. Kölsch,et al.  Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17β , 2001, Journal of Neural Transmission.

[22]  Cheng Luo,et al.  Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.

[23]  N. Bazan.  Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[24]  J. Wahren,et al.  Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. , 1998, Journal of lipid research.

[25]  P. Codogno,et al.  Increase in Ceramide Level Alters the Lysosomal Targeting of Cathepsin D prior to Onset of Apoptosis in HT-29 Colon Cancer Cells , 2002, Biological chemistry.

[26]  O. Gerasimenko,et al.  New aspects of nuclear calcium signalling , 2004, Journal of Cell Science.

[27]  B. Fahrenkrog.  The nuclear pore complex, nuclear transport, and apoptosis. , 2006, Canadian journal of physiology and pharmacology.

[28]  E. Albi,et al.  The role of intranuclear lipids , 2004, Biology of the cell.

[29]  R. Ledeen,et al.  Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling** This study was supported by National Institutes of Health grant 2RO1 NS033912. Published, JLR Papers in Press, March 9, 2008. , 2008, Journal of Lipid Research.

[30]  T. Willson,et al.  Polyunsaturated Fatty Acids Including Docosahexaenoic and Arachidonic Acid Bind to the Retinoid X Receptor α Ligand-binding Domain* , 2004, Molecular & Cellular Proteomics.

[31]  A. Gomez-Muñoz.  Ceramide 1-phosphate/ceramide, a switch between life and death. , 2006, Biochimica et biophysica acta.

[32]  M. V. Magni,et al.  Plasmalogens in rat liver chromatin: New molecules involved in cell proliferation , 2004, Journal of cellular physiology.

[33]  L. Horrocks,et al.  Excitatory Amino Acid Receptors in Brain , 2008 .

[34]  M. V. Magni,et al.  Nuclear sphingomyelin pathway in serum deprivation‐induced apoptosis of embryonic hippocampal cells , 2006, Journal of cellular physiology.

[35]  J. M. Ruiz-Albusac,et al.  25-Hydroxycholesterol has a dual effect on the proliferation of cultured rat astrocytes , 2006, Neuropharmacology.

[36]  L. Horrocks,et al.  Effect of Retinoic Acid on the Ca2+-Independent Phospholipase A2 in Nuclei of LA-N-1 Neuroblastoma Cells , 2004, Neurochemical Research.

[37]  A. Hunt,et al.  Dynamic lipidomics of the nucleus , 2006, Journal of cellular biochemistry.

[38]  A. Martelli,et al.  Nuclear phospholipase C: involvement in signal transduction. , 2005, Progress in lipid research.

[39]  A. A. Farooqui.  Neural Membranes: A Pandora’s Box of Lipid Mediators , 2009 .

[40]  I. Björkhem,et al.  Oxysterols and Alzheimer's disease , 2006, Acta neurologica Scandinavica. Supplementum.

[41]  M. V. Magni,et al.  Sphingomyelin-cholesterol and double stranded RNA relationship in the intranuclear complex. , 2007, Archives of biochemistry and biophysics.

[42]  A. A. Farooqui,et al.  Changes in Brain Cholesterol Metabolome After Excitotoxicity , 2010, Molecular Neurobiology.

[43]  M. Wenk,et al.  Non‐targeted profiling of lipids during kainate‐induced neuronal injury , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  I. Emerit,et al.  Hydroxynonenal, a component of clastogenic factors? , 1991, Free radical biology & medicine.

[45]  L. Horrocks,et al.  Retinoic acid-mediated phospholipase A2 signaling in the nucleus , 2004, Brain Research Reviews.

[46]  J. Han,et al.  7-Ketocholesterol enhances 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells , 2006, Journal of Neural Transmission.

[47]  B. Halliwell,et al.  Increase in Cholesterol and Cholesterol Oxidation Products, and Role of Cholesterol Oxidation Products in Kainate‐induced Neuronal Injury , 2003, Brain pathology.

[48]  N. Heveker,et al.  G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. , 2006, Canadian journal of physiology and pharmacology.

[49]  D. Friend,et al.  Purification of human lung leukotriene C4 synthase and preparation of a polyclonal antibody. , 1995, American journal of respiratory and critical care medicine.

[50]  R. Ledeen,et al.  Sphingolipids of the nucleus and their role in nuclear signaling. , 2006, Biochimica et biophysica acta.

[51]  A. Martelli,et al.  Nuclear inositides: facts and perspectives. , 2004, Pharmacology & therapeutics.

[52]  Andrew J. Brown,et al.  SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. , 2006, The Biochemical journal.

[53]  A. A. Spector,et al.  Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. , 2005, Microvascular research.

[54]  E. Albi,et al.  Nuclear membrane sphingomyelin-cholesterol changes in rat liver after hepatectomy. , 1999, Biochemical and biophysical research communications.

[55]  B. Halliwell,et al.  Distribution of hydroxynonenal-modified proteins in the kainate-lesioned rat hippocampus: evidence that hydroxynonenal formation precedes neuronal cell death. , 2000, Free radical biology & medicine.

[56]  E. Millanvoye-Van Brussel,et al.  Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2. , 2004, The Biochemical journal.

[57]  P. D. Drew,et al.  Cholesterol oxides induce programmed cell death in microglial cells. , 1998, Biochemical and biophysical research communications.

[58]  R. Irvine.  Nuclear inositide signalling -- expansion, structures and clarification. , 2006, Biochimica et biophysica acta.

[59]  A. Martelli,et al.  Nuclear diacylglycerol kinase‐ζ is a negative regulator of cell cycle progression in C2C12 mouse myoblasts , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  L. Horrocks,et al.  Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. , 2000, Chemistry and physics of lipids.

[61]  David S. Park,et al.  Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment , 2000, Neurobiology of Aging.

[62]  Y. Kim,et al.  Prevention of 7-ketocholesterol-induced mitochondrial damage and cell death by calmodulin inhibition , 2007, Brain Research.

[63]  P. Bruni,et al.  Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response. , 2006, Biochimica et biophysica acta.

[64]  A. A. Farooqui.  Hot Topics in Neural Membrane Lipidology , 2010 .

[65]  T. Okada,et al.  Sphingosine Kinase 2 Is a Nuclear Protein and Inhibits DNA Synthesis* , 2003, Journal of Biological Chemistry.

[66]  J. Gustafsson,et al.  Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. , 2009, Cell stem cell.

[67]  J. York,et al.  A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. , 2000, Science.

[68]  Xianlin Han.  Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease. , 2005, Current Alzheimer research.

[69]  Andrew J. Brown,et al.  Statins Inhibit Synthesis of an Oxysterol Ligand for the Liver X Receptor in Human Macrophages With Consequences for Cholesterol Flux , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[70]  G. Baldini,et al.  Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. , 2000, Cancer research.

[71]  S. Choufani,et al.  Proinflammatory Gene Induction by Platelet-Activating Factor Mediated Via Its Cognate Nuclear Receptor1 , 2002, The Journal of Immunology.

[72]  I. Pikuleva,et al.  Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. , 2003, Biochemistry.

[73]  R. Faustino,et al.  Ceramide regulation of nuclear protein imports⃞ Published, JLR Papers in Press, December 14, 2007. , 2008, Journal of Lipid Research.

[74]  J. Phillis,et al.  Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders , 2006, Brain Research Reviews.